Derek T. Chalmers, President & CEO at Cara Therapeutics, Inc. (CARA), sold 5,000 shares at $16.01 ($80K) on 2020-06-03, disclosed to the SEC on 2020-06-03.
Open-market sale of $80k CARA by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 700 | $11K | 14.0% |
| 2 | $16.01 | 4,300 | $69K | 86.0% |
| Total | $16.01 avg | 5,000 | $80K | 100% |
| Filing → |
| CARA | SELL | 2021-03-08 | $112K | — | Filing → |
| CARA | SELL | 2021-02-25 | $453K | — | Filing → |
| CARA | SELL | 2020-12-30 | $186K | — | Filing → |